{"organizations": [], "uuid": "2e94f27e3533e9a188cd69c8a981e83351c60d19", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cardinal-health-reports-q2-adj-ear/brief-cardinal-health-reports-q2-adj-earnings-per-share-1-31-idUSASB0C4R0", "country": "US", "domain_rank": 408, "title": "BRIEF-Cardinal Health Reports Q2 Adj. Earnings Per Share $1.31", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.016, "site_type": "news", "published": "2018-02-08T20:36:00.000+02:00", "replies_count": 0, "uuid": "2e94f27e3533e9a188cd69c8a981e83351c60d19"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cardinal-health-reports-q2-adj-ear/brief-cardinal-health-reports-q2-adj-earnings-per-share-1-31-idUSASB0C4R0", "ord_in_thread": 0, "title": "BRIEF-Cardinal Health Reports Q2 Adj. Earnings Per Share $1.31", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters) - cardinal health inc", "sentiment": "neutral"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Cardinal Health Inc:\n* CARDINAL HEALTH REPORTS SECOND-QUARTER RESULTS FOR FISCAL YEAR 2018\n* Q2 REVENUE $35.2 BILLION * RAISES FY 2018 NON-GAAP EARNINGS PER SHARE VIEW TO $5.25 TO $5.50\n* Q2 NON-GAAP EARNINGS PER SHARE $1.31 EXCLUDING ITEMS * COMPANY RAISES FY18 OUTLOOK TO REFLECT BENEFITS OF U.S. TAX REFORM\n* BOARD OF DIRECTORS APPROVES NEW $1 BILLION SHARE REPURCHASE AUTHORIZATION\n* CARDINAL HEALTH-FOR QUARTER ENDED DEC. 31, 2017, APPLICATION OF LOWER TAX RATE TO FISCAL YEAR-TO-DATE U.S. EARNINGS RESULTED IN A BENEFIT OF $0.20/SHARE\n* COMPANY IS RAISING ITS OUTLOOK FOR FISCAL 2018 NON-GAAP EPS TO $5.25-$5.50\n* SECOND-QUARTER REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 5 PERCENT TO $31.1 BILLION\n* QTRLY GAAP DILUTED EARNINGS PER SHARE INCREASES 226 PERCENT TO $3.33\n* AS PART OF U.S. TAX REFORM, CO RECORDED TRANSITIONAL TAX BENEFITS TOTALING $2.83PER SHARE IN QUARTER\n* EXCLUDING A $0.20 BENEFIT FROM TAX REFORM, QTRLY NON-GAAP EPS IS $1.31\n* QTRLY NON-GAAP EPS INCREASED 13 PERCENT TO $1.51 * Q2 REVENUE VIEW $34.64 BILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T20:36:00.000+02:00", "crawled": "2018-02-09T16:55:34.005+02:00", "highlightTitle": ""}